http://orcid.org/0000-0003-0636-9506
References
- Nomdedeu M, Pereira A, Ramos F, et al. Excess mortality in the myelodysplastic syndromes. Am J Hematol. 2017 Feb;92(2):149–154. doi: 10.1002/ajh.24606
- Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405. doi: 10.1182/blood-2016-03-643544
- Liu D, Chen Z, Xue Y, et al. The significance of bone marrow cell morphology and its correlation with cytogenetic features in the diagnosis of MDS-RA patients. Leuk Res. 2009;33:1029–1038. doi: 10.1016/j.leukres.2009.02.011
- Giagounidis A, Haase D. Morphology, cytogenetics and classification of MDS. Best Pract Res Clin Haematol. 2013;26:337–353. doi: 10.1016/j.beha.2013.09.004
- Spss I. SPSS 16.0 Base User’s Guide. Spss Inc. 2007;49:741–743.
- Germing U, Strupp C, Giagounidis A, et al. Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf registry on myelodysplastic syndromes. Clin Exp Immunol. 2012;175:333–335.
- Della Porta MG, Travaglino E, Boveri E, et al. Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes. Leu. 2015;29:66–75.
- He R, Wiktor AE, Durnick DK, et al. Bone marrow conventional karyotyping and fluorescence in Situ hybridization: defining an effective utilization strategy for evaluation of myelodysplastic syndromes. Am J Clin Pathol. 2016;39:S76.
- Nazha A, Sekeres MA. Improving prognostic modeling in myelodysplastic syndromes. Curr Hematol Malig Rep. 2016;11(6):395–401. doi: 10.1007/s11899-016-0342-1
- Park JH, Kim M, Kong SY, et al. Monitoring of the clonal fraction by fluorescence in Situ hybridization in myelodysplastic syndrome: comparison with international working group treatment response criteria. Arch Pathol Lab Med. 2016;140:560–569. doi: 10.5858/arpa.2015-0150-OA
- Schemenau J, Baldus S, Anlauf M, et al. Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes. Eur J Haematol. 2015;95:181–189. doi: 10.1111/ejh.12512
- Ganguly BB, Dolai TK, De R, et al. Spectrum of complex chromosomal aberrations in a myelodysplastic syndrome and a brief review. J Cancer Res Ther. 2016;12(3):1203–1206.
- Cao P, Li Y, Li X, et al. Detecting chromosomal aberrations in myelodysplastic syndrome with fluorescence in situ hybridization and conventional cytogenetic analysis. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014;39:605–611.